KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Current Liabilities: 2014-2025

Historic Total Current Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to $76.2 million.

  • Aurinia Pharmaceuticals' Total Current Liabilities fell 3.04% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 3.04%. This contributed to the annual value of $97.8 million for FY2024, which is 26.66% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Total Current Liabilities stood at $76.2 million, which was down 2.61% from $78.3 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Total Current Liabilities ranged from a high of $97.8 million in Q4 2024 and a low of $21.2 million during Q1 2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Total Current Liabilities had a median value of $76.2 million in 2025 and averaged $72.9 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Total Current Liabilities soared by 78.08% in 2023, and later fell by 3.72% in 2025.
  • Aurinia Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $40.6 million in 2021, then climbed by 13.44% to $46.1 million in 2022, then skyrocketed by 67.41% to $77.2 million in 2023, then climbed by 26.66% to $97.8 million in 2024, then decreased by 3.04% to $76.2 million in 2025.
  • Its Total Current Liabilities stands at $76.2 million for Q3 2025, versus $78.3 million for Q2 2025 and $68.4 million for Q1 2025.